LNTH · Transaction Jan 28, 2025 · Filed Feb 11, 2025 · $1,001 to $15,000
Lantheus Holdings, Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is LNTH moving today?
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
LNTH overview
Related filings and maps
Congress activity in LNTH
LNTH · Transaction Jan 13, 2025 · Filed Feb 11, 2025 · $1,001 to $15,000
LNTH · Transaction Jan 8, 2025 · Filed Feb 11, 2025 · $1,001 to $15,000
LNTH · Transaction Jan 7, 2025 · Filed Feb 11, 2025 · $1,001 to $15,000
LNTH contract awards, year to date.
Public federal awards linked to this ticker.
LNTH lobbying filings, year to date.
Registered lobbying filings matched to Lantheus Holdings, Inc.
LANTHEUS HOLDINGS, INC.
LANTHEUS HOLDINGS, INC.